Pages that link to "Q48100302"

The following pages link to P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice (Q48100302):

Displaying 23 items.

• Enteric microbiome metabolites correlate with response to simvastatin treatment (Q21135141) (← links)
• Improving the prediction of the brain disposition for orally administered drugs using BDDCS. (Q36394062) (← links)
• Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone (Q36856634) (← links)
• Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells (Q36913097) (← links)
• Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null mice (Q37462636) (← links)
• Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs (Q37521059) (← links)
• Efflux and uptake transporters as determinants of statin response. (Q37724381) (← links)
• Statins and neuroprotection: basic pharmacology needed (Q38182926) (← links)
• Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies. (Q38188290) (← links)
• The interplay between cell signalling and the mevalonate pathway in cancer (Q38937455) (← links)
• P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin (Q40025134) (← links)
• Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice (Q40101603) (← links)
• Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy (Q42722753) (← links)
• Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates (Q42911797) (← links)
• No clinically relevant drug–drug interactions when dalcetrapib is co-administered with atorvastatin (Q42926221) (← links)
• Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males (Q43248042) (← links)
• Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin (Q44991444) (← links)
• Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling (Q47125276) (← links)
• Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model. (Q53400396) (← links)
• Erythrocyte-mediated delivery of pravastatin: In Vitro study of effect of hypotonic lysis on biochemical parameters and loading efficiency (Q57535192) (← links)
• Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs (Q83743461) (← links)
• In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies (Q89169807) (← links)
• Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins (Q90020242) (← links)